Alliance for Pandemic Preparedness
October 5, 2020
A One-Minute Blood Test to Monitor Immune Responses in COVID-19 Patients and Predict Clinical Risks of Developing Moderate to Severe Symptoms
Category: Article Summary
Topic: Testing and Treatment
Keywords (Tags): testing
- [Preprint, not peer-reviewed] A nanoparticle-enabled blood test could detect a statistically significant differences in immune response between samples collected from COVID-19 patients with no or mild symptoms (n=38) and those with moderate/severe symptoms (n=115), with results available in <1 minute. The authors conclude this new rapid test may be used as a point-of-care clinical tool for COVID-19 patient risk stratification and management.
Deb et al. (Oct 2, 2020). A One-Minute Blood Test to Monitor Immune Responses in COVID-19 Patients and Predict Clinical Risks of Developing Moderate to Severe Symptoms. Preprint downloaded Oct 5 from https://doi.org/10.1101/2020.09.30.20203844